|
Friday, May 31, 2024, Chicago, Illinois, 11:45 AM – 12:45 PM Central Time (12:45 PM – 1:45 PM Eastern Time)
Lunch with the Investigators: Hepatobiliary CancersA CME Hybrid Symposium Held in Conjunction with the 2024 ASCO Annual Meeting
Location
Hilton Chicago 720 South Michigan Avenue Chicago, Illinois Phone: (312) 922-4400 Program Schedule — Central Time 11:15 AM – 11:45 AM — Registration and Lunch 11:45 AM – 12:45 PM — Educational Meeting Meeting Room Grand Ballroom (Level 2) This event will also be webcast live. Please see Registration tab for details. Faculty
Edward Kim, MD Director, Interventional Oncology Professor of Radiology and Surgery Division of Interventional Radiology Mount Sinai Health System New York, New York Arndt Vogel, MD, PhD Professor of Medicine, University of Toronto Longo Family Chair in Liver Cancer Research Division of Gastroenterology and Hepatology Toronto General Hospital Medical Oncology Princess Margaret Cancer Centre Toronto General Hospital Research Institute Schwartz Reisman Liver Research Centre Toronto, Ontario, Canada
Moderator
Robin K (Katie) Kelley, MD Professor of Clinical Medicine Division of Hematology/Oncology Helen Diller Family Comprehensive Cancer Center University of California, San Francisco (UCSF) San Francisco, California This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Incyte Corporation, Jazz Pharmaceuticals Inc, and Taiho Oncology Inc.
Program Schedule — Central Time
11:15 AM – 11:45 AM — Registration and Lunch 11:45 AM – 12:45 PM — Educational Meeting Discussion Topics
Target Audience
CME Credit Form Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education and adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited continuing education activity, including faculty, planners, reviewers and others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will have been mitigated prior to the commencement of this activity. In addition, all activity content is reviewed by RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided. FACULTY — Dr Kim has no relevant conflicts of interest to disclose. The following faculty reported relevant financial relationships with ineligible entities: Prof Vogel — Consultancy and Advisory; Speaker: Amgen Inc, AstraZeneca Pharmaceuticals LP, BeiGene Ltd, Boehringer Mannheim, Bristol Myers Squibb, Eisai Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, MSD, Pierre Fabre, Roche Laboratories Inc, Servier Pharmaceuticals LLC, Taiho Oncology Inc. MODERATOR — Dr Kelley — Advisory Committees (Payments to Institution): Agios Pharmaceuticals Inc, AstraZeneca Pharmaceuticals LP, Exelixis Inc, Ipsen Biopharmaceuticals Inc, Merck; Consulting Agreements (Payments to Self): Compass Therapeutics, Exact Sciences Corporation, GSK, J-Pharma Co Ltd, Kinnate Biopharma, Moderna, Regeneron Pharmaceuticals Inc, Tyra Biosciences; Contracted Research (Payment to Institution for Trial Conduct): Agios Pharmaceuticals Inc, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Bristol Myers Squibb, Compass Therapeutics, EMD Serono Inc, Exelixis Inc, Genentech, a member of the Roche Group, Lilly, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Merck, Partner Therapeutics, QED Therapeutics, Servier Pharmaceuticals LLC, Surface Oncology, Taiho Oncology Inc, Tyra Biosciences; Independent Data Monitoring Committees (Unpaid Service): Genentech, a member of the Roche Group, Merck. RESEARCH TO PRACTICE CME PLANNING COMMITTEE MEMBERS, STAFF AND REVIEWERS This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Incyte Corporation, Jazz Pharmaceuticals Inc, and Taiho Oncology Inc. Hilton Chicago
This activity is intended for medical oncologists, hematology-oncology fellows and other healthcare providers involved in the treatment of hepatobiliary cancers.
There is no registration fee for this event. For the in-person symposium in Chicago, preregistration is required as seating is limited. NOTICE: Registration for this event is independent of registration for the 2024 ASCO Annual Meeting. IN-PERSON Registration
Thank you for your interest in our CME program taking place in Chicago. At this time online registration to attend this event in person is closed. SEATS ARE STILL AVAILABLE FOR THE PROGRAM AND WILL BE OFFERED ON A FIRST COME, FIRST SERVED BASIS. Our onsite registration desk will be open at 11:15 AM central time on Friday, May 31st. If you are interested in attending, please visit our registration desk outside the Grand Ballroom (Level 2) of the Hilton Chicago hotel (720 South Michigan Avenue). ASCO offers complimentary shuttle service from the McCormick Place Convention Center to this hotel. Information on the shuttle service is available on the 2024 ASCO Annual Meeting website.
Please note, onsite registration does not guarantee seating or participation in the meal service, which will be based on availability. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. LIVE WEBCAST Registration for all professionals
Please note, we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. REGISTRATION FOR WEBCAST »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 15 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153. Not an official event of the 2024 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation. |